This study assessed biotin nutritional status longitudinally during pr
egnancy as judged by urinary excretion of biotin and biotin metabolite
s and by serum concentration of biotin. 3-Hydroxyisovaleric acid excre
tion was also assessed because increased excretion of that acid reflec
ts decreased tissue activity of the biotin-dependent enzyme, methylcro
tonyl-CoA carboxylase. Thirteen women provided untimed urine samples d
uring both early and late pregnancy. Twelve nonpregnant women served a
s controls. Biotin and metabolites were determined by a combined HPLC/
avidin-binding assay. 3-Hydroxyisovaleric acid was determined by gas c
hromatography/mass spectrophotometry. Significance of changes from ear
ly to late pregnancy was tested by paired t test; to compare nonpregna
nt controls with early and late pregnancy, ANOVA was used. During earl
y pregnancy, biotin excretion was not significantly different than con
trols; however, 3-hydroxyisovaleric acid excretion was significantly i
ncreased relative to controls (P < 0.0001) and was greater than the up
per limit of normal in 9 of 13 women. From early to late pregnancy, bi
otin excretion decreased in 10 of 13 women (P < 0.01); by late pregnan
cy, biotin excretion was less than normal in six women. During late pr
egnancy, 3-hydroxyisovaleric acid remained significantly increased rel
ative to controls (P < 0.0001). Serum concentrations of biotin were si
gnificantly greater than those of controls during early pregnancy (P <
0.0001) and decreased in each woman from early to late pregnancy (P <
0.0001). These data provide evidence that biotin status decreases dur
ing pregnancy.